3Dec GW. Acute decompensated heart failure:the shrinking role of inotropic therapy [ J ]. J Am Coll Cordial, 2005,46( 1 ) :65 -67.
4Moiseyev VS, Poder P,Andrejevs N, et al. Safety and efficacy of a novel calcium sensitizer,levosimendan,in patients with left ventrieular failure due to an acute myocardial infarction : A randomized, placebo-comrolled, doubleblind study ( RUSSLAN ) [ J ]. Eur Heart J, 2002,23 (18) :1 422-1 432.
5Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study) :a randomised double-blind trial [ J ]. Lancet, 2002, 360 ( 9 328) :196 -202.
6Cleland JG, Ghosh J, Freemanfle N, et al. Clinical trials update and cumulative meta-analyses from the American College of Cardiology : WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchranisation therapy in heart failure[ J ]. Eur J Heart Fail,2004,6 (4) :501 - 508. Review.
7Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretie peptide in the emergency diagnosis of heart failure[ J ]. N Engl J Med,2002, 347(2) :161 -167.
8Gheorghiade M, Abraham WT, Albert NM, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure [ J]. JAMA,2007,296(18) :2 217 -2 226.
2Rognoni A, Lupi A, Lazzero M, et al. Levosimendan : from basic science to clinical trials [ J ]. Recent Pat Cardiovasc Drug Discov,2011,6( 1 ) :9 - 15.
3Mebazaa A, Nieminen MS, Packer M, et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure :the SURVIVE Randomized Trim [ J ]. JAMA ,2007, 297 (17) : 1883 - 1891.
